COA verified
Certificate of Analysis available
≥99% purity (HPLC)
Pharmaceutical-grade standard
Fast dispatch
Orders ship within 24 hours
Peptide
Semaglutide
Purity ≥99% (HPLC). 10mg lyophilisate. For research purposes only.
Dosage
Research Library — app.uptide.eu
Mechanisms, studies, pathways & COA documentation
Pharmaceutical-grade research peptide, lyophilized for stability. Each batch is independently tested and COA-verified with ≥99% purity by HPLC analysis. Intended exclusively for research purposes.
Semaglutide is extensively studied as a GLP-1 receptor agonist with a strong human clinical evidence base. Research focuses on type 2 diabetes, obesity, appetite regulation, gastric emptying, glycaemic control, body weight and cardiometabolic risk factors. Large clinical trials such as the STEP programme have investigated weight reduction and metabolic outcomes in adults with obesity or overweight. Semaglutide is also being studied in the context of pre-diabetes, liver disease, cardiovascular outcomes and potentially neurodegenerative conditions.
For laboratory research use only. This information describes areas of scientific investigation and does not constitute medical advice, dosing guidance or therapeutic claims.
For research purposes only. All Uptide products are intended exclusively for research and analytical purposes by qualified professionals. Not for human consumption, diagnostic or therapeutic applications.